Sudafed (Pseudoephedrine/PE)

What pseudoephedrine hydrochloride is and how it works

Sudafed (pseudoephedrine) is an oral decongestant that narrows swollen blood vessels in the nose and sinuses, temporarily relieving nasal and sinus congestion from the common cold, hay fever, or other upper respiratory allergies. (1) (3)

Because pseudoephedrine works throughout the whole body, not just the nose, it has a real cardiovascular caution -- it can raise blood pressure and heart rate, so people with heart disease, high blood pressure, thyroid disease, or diabetes should check with a doctor or pharmacist first. A genuinely current safety finding (confirmed by EU and New Zealand regulators in 2023-2024) also found a rare but serious risk of reduced blood flow to the brain (conditions called PRES and RCVS), leading to a new rule that it should not be used by people with severe or poorly controlled high blood pressure or severe kidney disease. Separately, and for an entirely different reason, pseudoephedrine is sold 'behind the counter' with purchase limits and identification checks in every country covered on this page -- not because of a health risk to the person taking it, but because it is a real chemical precursor that can be misused to illegally manufacture methamphetamine.

Mechanism of action: how pseudoephedrine hydrochloride works

Pseudoephedrine is an indirect-acting sympathomimetic amine that stimulates alpha-adrenergic receptors in the nasal mucosa, causing vasoconstriction and reduced tissue swelling/congestion. Its systemic sympathomimetic activity is also responsible for its cardiovascular effects and stimulant-type CNS effects. (1)

What pseudoephedrine hydrochloride is used for

Before taking pseudoephedrine hydrochloride

Do not take / not appropriate for

• Do not use if you are taking (or have taken within the past 2 weeks) a prescription monoamine oxidase inhibitor (MAOI), used for depression or other psychiatric conditions or Parkinson's disease -- combining these can cause a dangerous rise in blood pressure. (all countries) (1) (4)
• Do not use if you have severe or poorly controlled high blood pressure, or severe kidney disease/failure. (European Union (and as general good practice elsewhere)) (3)
• Do not use if you have severe coronary artery disease. (all countries) (2)

Tell your clinician about

• Any heart disease, high blood pressure (even if controlled), thyroid disease, or diabetes, since pseudoephedrine can affect all of these.
• Any difficulty urinating due to an enlarged prostate gland.
• Any other decongestants or sympathomimetic medicines you take, to avoid combining stimulant-type effects.
• If you are pregnant or breastfeeding.
• If you have ever had an unusual reaction to pseudoephedrine or similar decongestants.

How to take pseudoephedrine hydrochloride

• Take exactly as directed on your product's label -- strength and maximum daily dose vary by product (standard tablets vs. 12-hour extended-release).
• Swallow extended-release tablets whole; do not crush or chew them.
• Do not take more than the labelled maximum in a 24-hour period.
• This medicine is sold behind the pharmacy counter (or after a pharmacist consultation) in every market covered here, as a real, legally required control on a chemical that can be diverted to illegal methamphetamine manufacture -- expect to show photo ID and have your purchase recorded or limited.
• New or worsening nervousness, dizziness, or trouble sleeping, or symptoms lasting more than 7 days or occurring with fever, call for medical review rather than continued self-treatment.

Procedures and treatment changes

Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6) (7) (8)

Missed dose

This is taken as needed for symptom relief rather than on a fixed schedule for most people, so there is no formal 'missed dose' to make up -- simply take your next dose when needed, without exceeding the maximum daily amount on the label.

Overdose

Taking more than the labelled maximum can increase the risk of nervousness, rapid heartbeat, high blood pressure, or, rarely, more serious cardiovascular effects. If an overdose is suspected, contact a doctor or poison control centre right away, especially in children, for whom accidental overdose can be more serious. (1)

Side effects

Side effects and their urgency vary; report severe, persistent, or concerning symptoms.

Serious warnings

Interactions

• Prescription MAOIs (monoamine oxidase inhibitors): contraindicated in combination, and for 2 weeks after stopping an MAOI, due to the risk of a severe rise in blood pressure. (1) (4)
• Other sympathomimetic decongestants or stimulant medicines: combining can increase cardiovascular stimulant effects. (4)
• Beta-blockers: concurrent use with pseudoephedrine is flagged as contraindicated in some product labelling due to blood-pressure effects. (4)

Pregnancy, breastfeeding, kidney/liver function, age

Monitoring

Before starting

• Confirm no severe/uncontrolled hypertension, severe kidney disease, or severe coronary artery disease.
• Confirm no MAOI use within the past 2 weeks.
• Review any heart disease, thyroid disease, diabetes, or prostate enlargement with a pharmacist or doctor first.

During treatment

• Watch for nervousness, rapid heartbeat, or a significant rise in blood pressure.
• Seek emergency care immediately for sudden severe headache, confusion, seizures, or visual disturbances (possible PRES/RCVS).
• Review with a doctor if symptoms persist beyond 7 days or occur with fever.

Storage

Store at controlled room temperature (approximately 20-25°C / 68-77°F) in the original, tightly closed container, out of reach of children.

Frequently asked questions

References

1. SUDAFED - pseudoephedrine hydrochloride tablet, coated - Drug Facts labelDailyMed (U.S. National Library of Medicine) / FDA-approved OTC Drug Facts label · United States · accessed 2026-07-30 · source 1
2. Pseudoephedrine cardiovascular and cerebrovascular adverse effect profileClinical pharmacology secondary literature summarizing FDA-label-consistent cardiovascular risk language for sympathomimetic decongestants · United States / international clinical literature · accessed 2026-07-30 · source 2
3. Pseudoephedrine-containing medicinal products -- referral (PRES/RCVS safety review)European Medicines Agency (EMA) -- Article 31 referral / PRAC safety review, CHMP opinion, European Commission decision · European Union · accessed 2026-07-30 · source 3
4. Sudafed Decongestant Tablets -- Summary of Product Characteristicselectronic medicines compendium (emc), United Kingdom -- Summary of Product Characteristics · United Kingdom · accessed 2026-07-30 · source 4
5. Restrictions on sale/supply of pseudoephedrine- and ephedrine-containing medicines in the UKUK Medicines and Healthcare products Regulatory Agency (MHRA) restriction, effective April 2008 (via UK Parliament Hansard and MHRA public assessment report) · United Kingdom · accessed 2026-07-30 · source 5
6. Order Establishing Supplementary Rules Respecting the Sale of Natural Health Products Containing Ephedrine or PseudoephedrineHealth Canada Ministerial Order (Canada Gazette, Part II) and National Association of Pharmacy Regulatory Authorities (NAPRA) · Canada · accessed 2026-07-30 · source 6
7. Sudafed Sinus and Nasal Decongestant / Sudafed Sinus 12 Hour Relief -- ARTG entries, and Project STOPTherapeutic Goods Administration (TGA), Australia -- ARTG entries; Pharmacy Guild of Australia's Project STOP real-time recording system · Australia · accessed 2026-07-30 · source 7
8. Spotlight on cold and flu medicines containing pseudoephedrineMedsafe (New Zealand regulator) -- Prescriber Update article, June 2024 · New Zealand · accessed 2026-07-30 · source 8

Brand names by country

Single-ingredient pseudoephedrine hydrochloride names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.

Priority countries